annual working capital:
$566.29M+$232.54M(+69.68%)Summary
- As of today (May 29, 2025), BBIO annual working capital is $566.29 million, with the most recent change of +$232.54 million (+69.68%) on December 31, 2024.
- During the last 3 years, BBIO annual working capital has fallen by -$187.50 million (-24.87%).
- BBIO annual working capital is now -24.87% below its all-time high of $753.79 million, reached on December 31, 2021.
Performance
BBIO Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$543.07M-$23.22M(-4.10%)Summary
- As of today (May 29, 2025), BBIO quarterly working capital is $543.07 million, with the most recent change of -$23.22 million (-4.10%) on March 31, 2025.
- Over the past year, BBIO quarterly working capital has dropped by -$98.88 million (-15.40%).
- BBIO quarterly working capital is now -36.86% below its all-time high of $860.04 million, reached on March 31, 2020.
Performance
BBIO quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
BBIO Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +69.7% | -15.4% |
3 y3 years | -24.9% | -11.4% |
5 y5 years | +11.4% | -36.9% |
BBIO Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -24.9% | +69.7% | -15.4% | +77.8% |
5 y | 5-year | -24.9% | +69.7% | -36.9% | +77.8% |
alltime | all time | -24.9% | +539.3% | -36.9% | +102.6% |
BBIO Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $543.07M(-4.1%) |
Dec 2024 | $566.29M(+69.7%) | $566.29M(+85.4%) |
Sep 2024 | - | $305.36M(-36.6%) |
Jun 2024 | - | $481.87M(-24.9%) |
Mar 2024 | - | $641.95M(+92.3%) |
Dec 2023 | $333.75M(-21.9%) | $333.75M(-30.7%) |
Sep 2023 | - | $481.61M(+49.2%) |
Jun 2023 | - | $322.76M(-29.2%) |
Mar 2023 | - | $456.11M(+6.7%) |
Dec 2022 | $427.43M(-43.3%) | $427.43M(-18.3%) |
Sep 2022 | - | $523.02M(-17.0%) |
Jun 2022 | - | $630.12M(+2.8%) |
Mar 2022 | - | $612.77M(-18.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $753.79M(+37.8%) | $753.79M(+38.6%) |
Sep 2021 | - | $543.89M(-30.1%) |
Jun 2021 | - | $777.96M(-8.5%) |
Mar 2021 | - | $850.38M(+55.4%) |
Dec 2020 | $547.18M(+7.7%) | $547.18M(-18.3%) |
Sep 2020 | - | $669.68M(-12.9%) |
Jun 2020 | - | $769.29M(-10.6%) |
Mar 2020 | - | $860.04M(+69.2%) |
Dec 2019 | $508.24M(+23.2%) | $508.24M(-1.9%) |
Sep 2019 | - | $518.30M(+93.4%) |
Jun 2019 | - | $268.00M(-22.8%) |
Mar 2019 | - | $347.00M(-15.9%) |
Dec 2018 | $412.65M(+365.8%) | $412.65M |
Dec 2017 | $88.58M | - |
FAQ
- What is BridgeBio Pharma annual working capital?
- What is the all time high annual working capital for BridgeBio Pharma?
- What is BridgeBio Pharma annual working capital year-on-year change?
- What is BridgeBio Pharma quarterly working capital?
- What is the all time high quarterly working capital for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly working capital year-on-year change?
What is BridgeBio Pharma annual working capital?
The current annual working capital of BBIO is $566.29M
What is the all time high annual working capital for BridgeBio Pharma?
BridgeBio Pharma all-time high annual working capital is $753.79M
What is BridgeBio Pharma annual working capital year-on-year change?
Over the past year, BBIO annual working capital has changed by +$232.54M (+69.68%)
What is BridgeBio Pharma quarterly working capital?
The current quarterly working capital of BBIO is $543.07M
What is the all time high quarterly working capital for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly working capital is $860.04M
What is BridgeBio Pharma quarterly working capital year-on-year change?
Over the past year, BBIO quarterly working capital has changed by -$98.88M (-15.40%)